ZELECIMENT
UNII F6J6Y9R4HT

Substance Identification & Data

This profile provides standardized clinical and technical data for Zeleciment, uniquely identified by the FDA Unique Ingredient Identifier (UNII) F6J6Y9R4HT.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2725863-34-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

F6J6Y9R4HT

CAS Registry Number

2725863-34-1

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ZELECIMENT

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C203153

National Cancer Institute reference terminology for clinical and research data.

INN ID

12542

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

NO-95

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Zeleciment. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ZELECIMENT

Common Names & Synonyms

FAB-G1 VH-CH1 CHAIN (1-227) (VH MUSMUS/HOMSAP (MUS MUSCULUS IGHV3-6*01 (84.5%) -(IGHD) -IGHJ2*01 (85.7%)L124>V (115)/HOMO SAPIENS IGHV4-30-4*01 (82.8%) -(IGHD) -IGHJ4*01 (85.7%) L123>T (114), CDR-IMGT (9.7.12) (26-34.52-58.97-108)) (1-119) -HOMO SAPIENS IGHG1*01 CH1-H(100%), G1M17 CH1 K120 (CH1 K120 (216) (120-217), HINGE 1-10 (218-227)) (120-217)), (222-214')-DISULFIDE WITH L-KAPPA LIGHT CHAIN (1'-214') (V-KAPPA (HOMO SAPIENS IGKV1-39*01 (85.3%) -IGKJ2*01 (100%), CDR-IMGT (6.3.9) (27-32.51-53.89-97)) (1'-107') -HOMO SAPIENS IGKC*01 (100%), KM3, A45.1(153), V101 (191) (108'-214')

IMMUNOGLOBULIN FAB-G1KAPPA (VH-CH1_L-KAPPA), ANTI-(HOMO SAPIENS TFRC (TRANSFERRIN RECEPTOR, TFR1, TFR1, CD71)), MONOCLONAL ANTIBODY

IMMUNOGLOBULIN FAB-G1KAPPA (VH-CH1_L-KAPPA), ANTI-(HOMO SAPIENS TFRC (TRANSFERRIN RECEPTOR, TFR1, TFR1, CD71)), MONOCLONAL ANTIBODY; FAB-G1 VH-CH1 CHAIN (1-227) (VH MUSMUS/HOMSAP (MUS MUSCULUS IGHV3-6*01 (84.5%) -(IGHD) -IGHJ2*01 (85.7%) L124>V (115)/HOMO SAPIENS IGHV4-30-4*01 (82.8%) -(IGHD) -IGHJ4*01 (85.7%) L123>T (114), CDR-IMGT (9.7.12) (26-34.52-58.97-108)) (1-119) -HOMO SAPIENS IGHG1*01 CH1-H (100%), G1M17 CH1 K120 (CH1 K120 (216) (120-217), HINGE 1-10 (218-227)) (120-227)), (222-214')-DISULFIDE WITH L-KAPPA LIGHT CHAIN (1'-214') (V-KAPPA (HOMO SAPIENS IGKV1-39*01 (85.3%) -IGKJ2*01 (100%), CDR-IMGT (6.3.9) (27-32.51-53.89-97)) (1'-107') -HOMO SAPIENS IGKC*01 (100%), KM3, A45.1 (153), V101 (191) (108'-214')), PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, CELL LINE CHO-K1, NON-GLYCOSYLATED

IMMUNOGLOBULIN IGG1 FAB FRAGMENT, ANTI-(HUMAN AND MACACA FASCICULARIS TRANSFERRIN RECEPTORS TYPE 1) (HUMAN-MUS MUSCULUS MONOCLONAL F5298 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL F5298 .KAPPA.-CHAIN

ZELECIMENT [INN]

ZELECIMENT [USAN]